Such alterations in the BBB in MCI and AD point toward the BBB as a target for therapeutic interventions and suggest that identifying strategies to maintain and rectify BBB function, reduce the accumulation of brain Aβ and hyperphosphorylated tau, and maintain neuronal function is essential to prevent or delay the onset of AD. Here, MAPT is linked to Alzheimer disease.